Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Home  /  Forum  /  Galapagos  /  Galapagos januari 2017

Ontvang nu dagelijks onze kooptips!

word abonnee

Aandeel Galapagos AEX:GLPG.NL, BE0003818359

  • 25,140 5 jun 2024 17:35
  • -0,280 (-1,10%) Dagrange 24,980 - 25,500
  • 49.503 Gem. (3M) 82,2K

Galapagos januari 2017

1.661 Posts
Pagina: «« 1 ... 59 60 61 62 63 ... 84 »» | Laatste | Omlaag ↓
  1. forum rang 4 Sentiment 23 januari 2017 17:43
    quote:

    B...K schreef op 23 januari 2017 17:31:

    [...]
    De "beleggers " die hoog van de daken schreeuwen we gaan naar de 80 - 100
    Die geven vandaag commentaar op mij en mooiweer dat Galapagos naar de 55 - 58 gaat.
    Ze willen het niet zien.Maar ze zullen het binnen een maand moeten geloven.

    Jullie zijn gewoon flauw bezig en genieten van de rode koersen, wat weer heel kinderachtig is
  2. egeltjemetstekel 23 januari 2017 17:43
    www.marketwatch.com/story/why-health-...

    Why health-care stocks aren’t moving after President Trump’s Obamacare executive order
    By Emma Court
    Published: Jan 23, 2017 10:33 a.m. ET

    2
    The directive is either symbolic or will bring the Affordable Care Act crashing down, experts say
    Getty Images
    President Donald Trump’s first executive order after his Friday inauguration reinforced his administration’s intent to repeal the Affordable Care Act and told federal agencies to reduce the law’s regulatory and economic impact.

    But reading the tea leaves has been a tall order. Experts differ wildly on whether the directive has any implications and where those effects may lie.

    Some insisted that the act is symbolic, a nod to campaign promises rather than an indication of near-term changes.

    “There is not likely to be much immediate initial change,” said Evercore ISI policy analyst Terry Haines, calling the executive order a “tone setter.”

    “In essence, this is pure Trump: more sound and fury than substantive impact,” said Height Securities analysts Spencer Perlman and Sumesh Sood.

    By contrast, Mizuho’s Sheryl Skolnick called it “the first death warrant for the ACA” and a “poison pen;” adding, “so much for a slow and smooth transition.”

    Read: Trump starts presidency by issuing executive order on health care, memo on regulations

    The mixed messages, along with the fact that negative effects on certain sectors have been predicted for months, may well explain the lack of health care stock volatility in the executive order’s aftermath.

    0:00 / 0:00
    Here's what Trump means for health care(1:41)
    President-elect Donald Trump's vow to "repeal and replace" the Affordable Care Act has created uncertainty in the health-care sector. Here's what Trump's policies mean for the future of health care.

    Health Care Select Sector SPDR XLV, -0.43% iShares U.S. Healthcare ETF IYH, -0.50% Fidelity MSCI Health Care Index FHLC, -0.57% and Vanguard Health Care Index Fund VHT, -0.60% shares were slightly down in morning trade Monday, as was the S&P 500 SPX, -0.44%

    Shares of the funds have risen 0.2%, 0.8%, 0.8% and 0.8% respectively over the last three months, compared with a 6.1% rise in the S&P 500.

    Much of the infrastructure of the ACA, also called Obamacare, is reinforced by a system of tax credits that subsidize plans on the exchange and an individual mandate that requires health coverage.

    Not enforcing the mandate or subsidizing plans could send the exchanges into disarray as early as this year, many have warned.

    Read more: What is the individual health insurance market and why is everyone so worried about it?

    Skolnick referenced both in her Saturday analyst note.

    The executive order, paired with a case called House v. Burwell that will determine the future of the subsidies, could risk 2017 exchange enrollment and price out health coverage for millions, she said.

    All portended only negative things to come for the hospital sector, which stands to lose when patients don’t pay their hospital bills, she said.

    “The best case was the status quo,” Skolnick said. “The worst case is yet to come.”

    Read more: What we know about President Trump’s post-Obamacare health plan

    But many subsectors only stand to benefit, other analysts said.

    The executive order, along with an administration-directed freeze on new regulations, are “market positive actions because they are signposts that show Trump keenly focused on regulatory relief for US businesses,” said Evercore ISI policy analyst Terry Haines.

    The executive order also nods to the importance of regulatory process in cabinet departments and agencies, Haines said, meaning any regulations can only be repealed through full rule making, which could take a year or longer.

    Regulatory process and the fact that heads of the Department of Health and Human Services and the Centers for Medicare and Medicaid Services haven’t yet been confirmed suggest nothing will change for some time, Haines said.

    See more about last week’s contentious hearing for Tom Price, HHS Secretary nominee

    The Friday order could be both political gesture and have practical intent, said RBC Capital Markets analyst Frank Morgan.

    “As we are in uncharted territory, it is difficult to assess what will happen practically as a result of the order; at a minimum, it is President Trump’s first symbolic gesture to repeal the ACA,” Morgan said.

    Weakening the individual mandate could harm the ACA’s marketplaces, but the executive order could also make the market more attractive to consumers by relaxing federal regulations there, he said.
  8. [verwijderd] 23 januari 2017 19:02
    quote:

    ooievaar49 schreef op 23 januari 2017 18:59:

    Het begint zo langzamerhand op vorig jaar te lijken. Toen ook een mooie koerssprong in december 2015 en in januari 2016 het begin van een daling in de 30ers!!!
    Hmm. Interessante observatie. Verder val mij ook op dat het in 2015 ook rond January winter was, en pas veel later lente. Kijken of dat ook in 2017 zo is? Zou wat zijn zeg!
  13. Madagaskar 23 januari 2017 22:12
    At the same time AbbVie is able to dictate to smaller-cap biotech stocks and one such partner is Galapagos (NASDAQ:GLPG). AbbVie and Galapagos have teamed up in the fight against cystic fibrosis and are currently in Phase 2 for GLPG1837 which showed good results recently. Cystic fibrosis is a life-threatening disease which affects the lungs and digestive system with no known cure yet. Approximately 200,000 new patients are diagnosed each year in the U.S. Cystic Fibrosis is usually detected early on in life but also can develop in individuals predominately into their 40's.
  14. forum rang 10 voda 23 januari 2017 22:17
    Beursupdate: AEX op Wall Street

    ASML hoger, Galapagos grootste verliezer.

    (ABM FN-Dow Jones) Op Wall Street zijn maandag zeven van de negen AEX-genoteerde fondsen ten opzichte van het slot in Amsterdam hoger gesloten.

    Aegon (0,62%)
    ArcelorMittal (0,60%)
    ASML (0,68%)
    Galapagos (-0,53%)
    ING Groep (0,49%)
    Philips (0,41%)
    RELX (0,35%)
    Royal Dutch Shell (-0,17%)
    Unilever (0,37%)

    Euro/dollar: 1,0743

    Op basis van de bovenstaande koersuitslagen zou de AEX index, die sloot op 482,71 punten, zijn geëindigd op 483,68 punten.

    Door: ABM Financial News.

    info@abmfn.nl

    Redactie: +31(0)20 26 28 999

    Copyright ABM Financial News. All rights reserved

    (END) Dow Jones Newswires
1.661 Posts
Pagina: «« 1 ... 59 60 61 62 63 ... 84 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium

Weinig houvast voor beleggers in Galapagos

Het laatste advies leest u als abonnee van IEX Premium

Inloggen Word Abonnee

Galapagos Nieuws

  1. 30 mei Galapagos gaat samenwerken met Adaptimmune
  2. 16 mei Galapagos creëert nieuwe inschrijvingsrechtenplannen 1
  3. 16 mei Beursblik: KBC Securities zet Galapagos op Kopen 1
  4. 16 mei Galapagos kondigt samenwerking aan met Blood Centers of America
  5. 07 mei Beursblik: UBS verlaagt koersdoel Galapagos
  6. 03 mei Beursblik: hoge cashburn Galapagos 1
  7. 02 mei Galapagos handhaaft verwachte cashburn
  8. 01 mei Aandeelhouders Galapagos keuren alle agendapunten goed
  9. 12 apr KBC Securities verlaagt koersdoel Galapagos naar 50 euro
  10. 05 apr Galapagos toont innovatieve aanpak in hematologische kankerzorg

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Meld u aan voor de dagelijkse Beursupdate

Dagelijks een update van het laatste beursnieuws en beleggingskansen in uw mailbox!